Fluoride: Page 56

FTC campaigns against 'pay-for-delay'
By DrBicuspid.com staff writers
The U.S. Federal Trade Commission (FTC) is trying to stop drug companies from paying each other not to introduce competing products, according to commission Chairman Jon Leibowitz.
July 28, 2010
Agencies plan painkiller restrictions
By DrBicuspid.com staff writers
Washington state is preparing regulations intended to curb the overuse of prescription painkillers, according to an article in the New York Times.
July 28, 2010
Sanofi-Aventis, Novalar eye European market for OraVerse
By DrBicuspid.com staff writers
Sanofi-Aventis and Novalar Pharmaceuticals announced that the Marketing Authorization Application for OraVerse has been accepted for review by the regulatory agencies of the U.K., Germany, Italy, France, and Spain.
July 22, 2010
Antidepressants help manage trigeminal nerve injuries
By DrBicuspid.com staff writers
Pharmacologic management can be used to treat trigeminal nerve injury pain after dental implant surgery, according to a new study.
July 11, 2010
Study identifies possible cause of ONJ
By DrBicuspid.com staff writers
Osteonecrosis of the jaw (ONJ) could be caused by an interaction between nitrogen-containing bisphosphonates and compromised vitamin D function, according to a new animal study.
July 6, 2010
W.Va. woman sues dentist after implant surgery
By DrBicuspid.com staff writers
A West Virginia woman is suing Simpson Dental Associates of Charleston and a dentist for dental malpractice following an unsuccessful implant surgery, according to a news story in the West Virginia Record.
June 28, 2010
Merck loses retrial of Fosamax/ONJ case
By DrBicuspid.com staff writers
Merck has been ordered to pay $8 million in compensatory damages to a 72-year-old woman who claimed the company's bisphosphonate drug Fosamax caused her to develop osteonecrosis of the jaw (ONJ) and related dental problems.
June 27, 2010
Pharmacy module added to Dental Optimizer
By DrBicuspid.com staff writers
Dental Optimizer, a free online oral health application, now features a pharmacy module designed to allow patients to find out if the medications they are taking may impact their oral health.
June 13, 2010
Fosamax retrial now under way
By DrBicuspid.com staff writers
The retrial of the Fosamax/osteonecrosis of the jaw (ONJ) trial that ended in a mistrial last year got under way June 7 in the U.S. District Court for the Southern District of New York.
June 10, 2010
Patients on bisphosphonates may be unaware of BON risk
By Rabia Mughal
Patients who take bisphosphonates may not be aware that bisphosphonate-associated osteonecrosis (BON) can develop after they undergo invasive dental care, according to a study in the Journal of the American Dental Association.
June 2, 2010
2010 06 02 16 21 01 409 Confused Patient 70
Fosamax/ONJ retrial to begin June 2
By DrBicuspid.com staff writers
A new trial is scheduled to begin June 2 for the Fosamax/osteonecrosis of the jaw (ONJ) case that ended in a mistrial last September.
May 24, 2010
Merck triumphs in 2nd Fosamax trial
By DrBicuspid.com staff writers
A federal court jury in New York has found in favor of Merck in the second trial involving the pharmaceutical company's Fosamax bisphosphonate drug. The jury unanimously rejected the claims of a plaintiff who blamed her dental and jaw-related problems on her Fosamax use, according to the company.
May 4, 2010
Previous Page
Page 56 of 61
Next Page